| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |